6-methyl-2-ethyl-3-hydroxypyridine has been researched along with Diabetic Neuropathies in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Miroshnichenko, IIu; Rassokhina, LM; Volchegorskiĭ, IA | 1 |
| Chashchina, EN; Moskvicheva, MG; Volchegorskiĭ, IA | 1 |
2 other study(ies) available for 6-methyl-2-ethyl-3-hydroxypyridine and Diabetic Neuropathies
| Article | Year |
|---|---|
[Antihypoxic effect of 3-hydroxypyridine and succinic acid derivatives and their nootropic action in alloxan diabetes].
Topics: Alloxan; Animals; Conditioning, Classical; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Dose-Response Relationship, Drug; Female; Hyperglycemia; Hyperlipidemias; Hypoxia; Male; Meglumine; Mice; Nootropic Agents; Picolines; Pyridines; Rats; Succinates; Thioctic Acid | 2011 |
[An effect of antioxidant drugs on symptoms of sensomotor polyneuropathy and affective disorders in patients with diabetes mellitus].
Topics: Aged; Antioxidants; Anxiety Disorders; Data Interpretation, Statistical; Depressive Disorder; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Female; Follow-Up Studies; Humans; Hypoglycemic Agents; Male; Middle Aged; Picolines; Psychotropic Drugs; Time Factors; Treatment Outcome | 2005 |